Growth Metrics

Terns Pharmaceuticals (TERN) Change in Account Payables (2020 - 2023)

Terns Pharmaceuticals' Change in Account Payables history spans 4 years, with the latest figure at -$810000.0 for Q4 2023.

  • For Q4 2023, Change in Account Payables fell 71.97% year-over-year to -$810000.0; the TTM value through Dec 2023 reached $1.1 million, up 259.14%, while the annual FY2025 figure was -$512000.0, 39.51% down from the prior year.
  • Change in Account Payables reached -$810000.0 in Q4 2023 per TERN's latest filing, up from -$2.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.8 million in Q2 2023 to a low of -$2.2 million in Q3 2023.
  • Average Change in Account Payables over 4 years is $63000.0, with a median of -$175500.0 recorded in 2020.
  • Peak YoY movement for Change in Account Payables: surged 1586.67% in 2021, then plummeted 356.02% in 2023.
  • A 4-year view of Change in Account Payables shows it stood at $30000.0 in 2020, then soared by 1586.67% to $506000.0 in 2021, then crashed by 193.08% to -$471000.0 in 2022, then plummeted by 71.97% to -$810000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Change in Account Payables are -$810000.0 (Q4 2023), -$2.2 million (Q3 2023), and $2.8 million (Q2 2023).